E-Mail
DURHAM, N.C. - A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic.
The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body s cell receptors and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans.
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2021
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Week ahead: March 1 to March 5, 2021: Tracking the vaccines
norwich.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from norwich.edu Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
John C. Landon, Founder of BIOQUAL, Inc., Passes Away at the Age Of 84
January 22, 2021 GMT
ROCKVILLE, Md. (BUSINESS WIRE) Jan 22, 2021
Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021, at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College (class of 1959) and M.S. and Ph.D. degrees in biology from The George Washington University in 1962 and 1967, respectively. John worked for most of his career in Maryland, but spent his summers in Brewster, Massachusetts, which he retired to in 2013.